Overview · Filed: Jul 4, 2025
UPC_CFI_624/2025
ANALYTE SENSOR METHODS
Provisional measuresProvisional MeasuresThe Hague LDProvisional measuresCase Closed
This case cites
Authorities cited within the decisions on file for this case.
UPC Court of Appeal · 3
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| UPC_CoA_534/2024 | delivery up to bailiff as proportionate provisional measure | Persuasive | See also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips |
| UPC_CoA_683/2024 | delivery up to bailiff as proportionate provisional measure | Persuasive | See also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips |
| UPC_CoA_19/2025 | delivery up to bailiff as proportionate provisional measure | Persuasive | See also UPC CoA 3.10.2025 UPC_CoA_534/2024, UPC_CoA_683/2024 and UPC_CoA_19/2025), Belkin/Philips |
Rules of Procedure · 2
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| 211 | provisional measures | Binding | ORDER of the Court of First Instance of the Unified Patent Court Local Division in The Hague issued on 17 October 2025 concerning EP4344633 (R.211 provisional measures) |
| 206.2 | imminent infringement | Binding | By obtaining (and publicly announcing) CE-mark approval for the attacked (implantable) medical devices, providing 'ordering information' and announcing to show-case their products on a trade fair, the Defendants have set the stage to market these products, R. 206.2 lit. c) RoP. |
courtName.other · 2
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| EU Regulation 608/2013 Art. 2(7)(a) | goods suspected of infringing IP right — customs regulation | Binding | The requested declaration that the GlucoMen iCan is considered 'goods suspected of infringing an intellectual property right' within the meaning of Article 2(7)(a) of Regulation (EU) No 608/2013, is dismissed. |
| EU Regulation 2017/745 Art. 5(1) | CE marking required for placing medical device on EU market — imminent infringement | Binding | Since a CE marking is required for placing a medical device in any of the EU member states, obtaining such a CE-mark approval gives an indication of an expected market entry (Art. 5.1 regulation (EU) 2017/745 on medical devices, Art. 33 (1) lit. a UPCA). |
EPC article · 1
| Target | Legal point | Strength | Excerpt |
|---|---|---|---|
| Article 33(1) UPCA | competence — place of infringement | Binding | Art. 5.1 regulation (EU) 2017/745 on medical devices, Art. 33 (1) lit. a UPCA |
Cited by
Subsequent UPC decisions citing this case.
Not yet cited in another decision in our corpus.